Spero Therapeutics Inc
NASDAQ:SPRO

Watchlist Manager
Spero Therapeutics Inc Logo
Spero Therapeutics Inc
NASDAQ:SPRO
Watchlist
Price: 0.9632 USD 0.85%
Market Cap: 52.5m USD
Have any thoughts about
Spero Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Spero Therapeutics Inc

Current Assets 131.6m
Cash & Short-Term Investments 76.3m
Receivables 53.3m
Other Current Assets 2.1m
Non-Current Assets 3.5m
PP&E 3.4m
Other Non-Current Assets 153k
Current Liabilities 49.1m
Accounts Payable 6.1m
Accrued Liabilities 17.1m
Other Current Liabilities 25.9m
Non-Current Liabilities 20.6m
Other Non-Current Liabilities 20.6m

Balance Sheet
Spero Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
6
10
87
34
30
85
113
109
76
Cash Equivalents
6
10
87
34
30
85
113
109
76
Short-Term Investments
0
0
0
81
52
42
34
0
0
Total Receivables
0
0
3
1
9
6
3
1
51
Other Current Assets
0
1
2
8
5
6
9
3
4
Total Current Assets
6
12
92
124
95
139
158
114
131
PP&E Net
1
2
1
3
7
9
8
6
4
PP&E Gross
1
2
1
3
7
9
8
6
4
Accumulated Depreciation
0
0
1
1
2
2
3
3
4
Note Receivable
0
0
0
0
0
0
0
0
47
Other Long-Term Assets
0
0
0
2
4
5
6
6
0
Total Assets
7
N/A
14
+92%
94
+578%
129
+38%
106
-18%
154
+45%
171
+11%
125
-27%
182
+46%
Liabilities
Accounts Payable
2
1
4
4
4
1
1
1
1
Accrued Liabilities
1
3
4
8
23
13
16
11
8
Short-Term Debt
0
0
0
0
0
0
0
0
0
Other Current Liabilities
4
3
0
1
0
0
2
10
28
Total Current Liabilities
6
7
8
12
27
14
19
22
37
Long-Term Debt
0
0
0
0
0
0
48
0
0
Minority Interest
1
4
0
0
0
0
0
0
0
Other Liabilities
1
1
0
1
5
7
16
27
38
Total Liabilities
7
N/A
4
-49%
9
+147%
14
+52%
32
+133%
21
-32%
83
+287%
49
-41%
75
+54%
Equity
Common Stock
18
56
0
0
0
0
0
0
0
Retained Earnings
18
45
97
139
199
278
368
414
391
Additional Paid In Capital
0
0
181
254
274
410
456
490
498
Other Equity
0
0
0
0
0
0
0
0
0
Total Equity
0
N/A
10
+5 000%
85
+729%
116
+37%
75
-35%
132
+77%
88
-33%
76
-14%
107
+41%
Total Liabilities & Equity
7
N/A
14
+92%
94
+578%
129
+38%
106
-18%
154
+45%
171
+11%
125
-27%
182
+46%
Shares Outstanding
Common Shares Outstanding
14
14
14
17
19
29
32
53
53
Preferred Shares Outstanding
0
0
0
0
0
3
3
0
0

See Also

Discover More